Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
49 hedge funds and large institutions have $49M invested in Marrone Bio Innovations, Inc. in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 6 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
6% less funds holding
Funds holding: 52 → 49 (-3)
27% less capital invested
Capital invested by funds: $67.1M → $49M (-$18.1M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.06M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$616K |
| 3 |
Morgan Stanley
New York
|
+$67K |
| 4 |
JP Morgan Chase
New York
|
+$61.7K |
| 5 |
FC
Fairpointe Capital
Chicago,
Illinois
|
+$60.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$380K |
| 2 |
Millennium Management
New York
|
-$161K |
| 3 |
Goldman Sachs
New York
|
-$130K |
| 4 |
BlackRock
New York
|
-$82.3K |
| 5 |
Primecap Management
Pasadena,
California
|
-$36.4K |
MBII Hedge Fund Activity: Q4 2019 in Review
49 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2019, worth a combined $49M — down 27% from $67.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of MBII and 3 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 17 added.
The largest buyer was Ardsley Advisory Partners, adding an estimated $1.06M. The largest seller was Waddell & Reed Financial, cutting an estimated $380K.
- 49 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2019, down from 52 in Q3 2019.
- Funds reported $49M of Marrone Bio Innovations, Inc. stock for Q4 2019, down 27% quarter-over-quarter.
- 3 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2019 and 6 closed out, a net change of -3 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2019 was Ardsley Advisory Partners, an estimated $1.06M added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2019 was Waddell & Reed Financial, an estimated $380K sold.
Based on aggregated 13F filings for Q4 2019.